Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed EBT Margin for 8 consecutive years, with 501.92% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 152536.0% year-over-year to 501.92%, compared with a TTM value of 2446.39% through Sep 2025, up 40016.0%, and an annual FY2024 reading of 726.75%, up 417920.0% over the prior year.
  • EBT Margin was 501.92% for Q3 2025 at Bicycle Therapeutics, up from 2711.75% in the prior quarter.
  • Across five years, EBT Margin topped out at 321.52% in Q4 2023 and bottomed at 2711.75% in Q2 2025.
  • Average EBT Margin over 5 years is 841.81%, with a median of 619.84% recorded in 2025.
  • The sharpest move saw EBT Margin skyrocketed 211924bps in 2022, then crashed -228768bps in 2025.
  • Year by year, EBT Margin stood at 2481.12% in 2021, then skyrocketed by 85bps to 361.88% in 2022, then soared by 189bps to 321.52% in 2023, then plummeted by -282bps to 585.45% in 2024, then grew by 14bps to 501.92% in 2025.
  • Business Quant data shows EBT Margin for BCYC at 501.92% in Q3 2025, 2711.75% in Q2 2025, and 619.84% in Q1 2025.